文献速递中药与中成药合理使用中医儿科

丹酚酸A靶向3C蛋白酶抑制肠道病毒71型感染的计算机与实验研究

Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection.
PubMed 文献 · Front Pharmacol · 2023-03-02

手足口病主要由肠道病毒71型(EV71)引起,目前尚无临床可用的抗EV71特异性药物。该研究基于中药单体库进行虚拟筛选与生物学实验,鉴定出丹参多酚类单体丹酚酸A(SA)能以浓度依赖方式抑制EV71感染,抗病毒活性高于其他已报道的天然多酚且生物安全性高。分子动力学模拟显示SA可锚定于3Cpro催化三联体成员E71,使H40远离催化中心,提示SA是新型EV71 3Cpro抑制剂和候选临床研究药物。

要点

  • 丹酚酸A以浓度依赖方式抑制EV71感染,生物安全性高。
  • SA抗EV71活性高于其他已报道的天然多酚。
  • SA锚定3Cpro的E71并使H40远离催化中心。

核心结论

  • 丹酚酸A是新型EV71 3Cpro抑制剂,具有优异抗病毒活性,是有前景的临床研究候选药物。

研究设计与样本

  • 基于中药单体库进行虚拟筛选,并结合生物学实验验证。
  • 采用分子动力学模拟、MMGBSA和SMD分析SA与3Cpro的相互作用。

主要发现

  • 丹酚酸A以浓度依赖方式抑制EV71病毒感染,抗病毒活性高于其他已报道的天然多酚且生物安全性高。
  • 分子动力学模拟显示SA可锚定于3Cpro催化三联体成员E71,并使H40远离催化中心。
  • MMGBSA和SMD结果显示SA的P1基团最易从3Cpro的S1口袋解离,为改善SA与3Cpro亲和力提供理论支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hand, foot, and mouth disease (HFMD) is a common childhood infectious disease caused by enterovirus (EV) infection. EV71 is one of the major pathogens causing hand, foot, and mouth disease and is more likely to cause exacerbation and death than other enteroviruses. Although a monovalent vaccine for EV71 has been developed, there are no clinically available anti-EV71 specific drugs. Here, we performed virtual screening and biological experiments based on the traditional Chinese medicine monomer library. We identified a traditional Chinese medicine monomer, Salvianolic acid A (SA), a polyphenolic compound isolated from Salvia miltiorrhiza. Salvianolic acid A inhibits EV71 virus infection in a concentration-dependent manner, and its antiviral activity is higher than that of other reported natural polyphenols and has a high biosafety. Furthermore, molecular dynamics simulations showed that salvianolic acid A can anchor to E71, a member of the enzyme catalytic triad, and cause H40 to move away from the catalytic center. Meanwhile, molecular mechanics generalized born surface area (MMGBSA) and steered molecular dynamics (SMD) results showed that the P1 group of SA was most easily unbound to the S1 pocket of 3Cpro, which provided theoretical support to further improve the affinity of salvianolic acid A with 3Cpro. These findings suggest that salvianolic acid A is a novel EV71 3Cpro inhibitor with excellent antiviral activity and is a promising candidate for clinical studies.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Shi S, Xie L, Ma S, et al. Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection. Front Pharmacol. 2023. PMID: 36937869. doi:10.3389/fphar.2023.1118584

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。